Maimonides Cancer Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Daiichi Sankyo1 trial

Running trials

• Recruiting

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· Phase 3· Daiichi Sankyo· Source

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Eli Lilly and Company· Source

  Contact: Julie Huang (principal investigator)

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting